Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature-Reference-Cited by-同舟云学术

Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature

Published:2012-12 Issue:6 Volume:130 Page:956-966
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Douxfils Jonathan,Mullier François,Loosen Claire,Chatelain Christian,Chatelain Bernard,Dogné Jean-Michel

Publisher

Elsevier BV

Subject

Hematology

Reference48 articles.

1. Rivaroxaban: an oral direct inhibitor of factor Xa;Gulseth;Am J Health Syst Pharm,2008

2. EMA. Xarelto-H-C-000944-II-0012: EPAR - Assessment Report - Variation. In: CHMP, editor. Accessed on 10th February 2012 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000944/WC500120735.pdf.

3. Rivaroxaban in Patients with a Recent Acute Coronary Syndrome;Mega;N Engl J Med,2011

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Evaluation of Interferences Associated with Factor XIa Inhibitors Asundexian and Milvexian in Routine Coagulation Assays;Diagnostics;2024-09-09

2. Co-Administration of Amiodarone Increases Bleeding by Affecting Rivaroxaban Pharmacokinetics in Patients with Atrial Fibrillation;Pharmaceutics;2024-07-30

3. A specific fluorescence resonance energy quenching–based biosensor for measuring thrombin activity in whole blood;Journal of Thrombosis and Haemostasis;2024-06

4. Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation;Frontiers in Pharmacology;2024-05-10

5. Detection of direct oral anticoagulants with the diluted Russel's viper venom time;International Journal of Laboratory Hematology;2024-05-09